BAY-X1005   Click here for help

GtoPdb Ligand ID: 5148

Synonyms: BAY X 1005 | DG-031 | veliflapon
PDB Ligand
Compound class: Synthetic organic
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 1
Rotatable bonds 6
Topological polar surface area 59.42
Molecular weight 361.17
XLogP 5.36
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OC(=O)C(c1ccc(cc1)OCc1ccc2c(n1)cccc2)C1CCCC1
Isomeric SMILES OC(=O)[C@@H](c1ccc(cc1)OCc1ccc2c(n1)cccc2)C1CCCC1
InChI InChI=1S/C23H23NO3/c25-23(26)22(17-6-1-2-7-17)18-10-13-20(14-11-18)27-15-19-12-9-16-5-3-4-8-21(16)24-19/h3-5,8-14,17,22H,1-2,6-7,15H2,(H,25,26)/t22-/m1/s1
InChI Key ZEYYDOLCHFETHQ-JOCHJYFZSA-N
References
1. Dixon RA, Diehl RE, Opas E, Rands E, Vickers PJ, Evans JF, Gillard JW, Miller DK. (1990)
Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis.
Nature, 343 (6255): 282-4. [PMID:2300173]
2. Hatzelmann A, Fruchtmann R, Mohrs KH, Raddatz S, Müller-Peddinghaus R. (1993)
Mode of action of the new selective leukotriene synthesis inhibitor BAY X 1005 ((R)-2-[4-(quinolin-2-yl-methoxy)phenyl]-2-cyclopentyl acetic acid) and structurally related compounds.
Biochem Pharmacol, 45 (1): 101-11. [PMID:8381000]